Literature DB >> 4555718

Treatment of prostatic cancer: studies by the Veterans Administration cooperative urological research group.

D P Byar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4555718      PMCID： PMC1806744     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN： 0028-7091


× No keyword cloud information.
  1 in total

1.  Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate.

Authors:  C E Blackard; R P Doe; G T Mellinger; D P Byar
Journal:  Cancer       Date:  1970-08       Impact factor: 6.860
  1 in total
  8 in total

Review 1.  Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina.

Authors:  M A Sperling
Journal:  West J Med       Date:  1975-01

2.  Trends and racial differences in the use of androgen deprivation therapy for metastatic prostate cancer.

Authors:  April P Carson; Daniel L Howard; William R Carpenter; Yhenneko J Taylor; Sharon Peacock; Anna P Schenck; Paul A Godley
Journal:  J Pain Symptom Manage       Date:  2010-05       Impact factor: 3.612

Review 3.  Hormonal aspects of prostatic cancer: a review.

Authors:  J Waxman
Journal:  J R Soc Med       Date:  1985-02       Impact factor: 5.344

Review 4.  Immediate versus deferred treatment for early prostatic cancer.

Authors:  P H Smith; T G Armitage
Journal:  Postgrad Med J       Date:  1987-12       Impact factor: 2.401

Review 5.  Drug-induced cardiovascular diseases.

Authors:  S M Deglin; J M Deglin; E K Chung
Journal:  Drugs       Date:  1977-07       Impact factor: 9.546

6.  Metabolic effects of oestrogen treatment in patients with carcinoma of prostate: a comparison of stilboestrol and conjugated equine oestrogens.

Authors:  M Shahmanesh; C H Bolton; R C Feneley; M Hartog
Journal:  Br Med J       Date:  1973-06-02

7.  A patient-level data meta-analysis of standard-of-care treatments from eight prostate cancer clinical trials.

Authors:  N Geifman; A J Butte
Journal:  Sci Data       Date:  2016-05-10       Impact factor: 6.444

Review 8.  Cardiovascular effects of hormone therapy for prostate cancer.

Authors:  Jason F Lester; Malcolm D Mason
Journal:  Drug Healthc Patient Saf       Date:  2015-07-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.